000 01121 a2200337 4500
005 20250511123025.0
264 0 _c19760102
008 197601s 0 0 eng d
022 _a0006-3223
040 _aNLM
_beng
_cNLM
100 1 _aHimwich, H E
245 0 0 _aSummary of symposium.
_h[electronic resource]
260 _bBiological psychiatry
_cAug 1975
300 _a453-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aAutistic Disorder
_xcomplications
650 0 4 _aBrain
_xphysiopathology
650 0 4 _aBufotenin
_xurine
650 0 4 _aCentral Nervous System Diseases
_xcomplications
650 0 4 _aElectroencephalography
650 0 4 _aEvoked Potentials
650 0 4 _aHumans
650 0 4 _aIntellectual Disability
_xcomplications
650 0 4 _aLanguage Disorders
_xcomplications
650 0 4 _aMovement Disorders
_xcomplications
650 0 4 _aPhenothiazines
650 0 4 _aThiothixene
_xtherapeutic use
650 0 4 _aTriiodothyronine
_xtherapeutic use
773 0 _tBiological psychiatry
_gvol. 10
_gno. 4
_gp. 453-8
999 _c265738
_d265738